ID   POMT1_HUMAN             Reviewed;         747 AA.
AC   Q9Y6A1; B3KQG0; B4DIF0; Q5JT01; Q5JT06; Q5JT08; Q8NC91; Q8TCA9;
AC   Q9NX32; Q9NX82; Q9UNT2;
DT   20-JUN-2003, integrated into UniProtKB/Swiss-Prot.
DT   03-MAY-2011, sequence version 3.
DT   10-MAY-2017, entry version 159.
DE   RecName: Full=Protein O-mannosyl-transferase 1;
DE            EC=2.4.1.109;
DE   AltName: Full=Dolichyl-phosphate-mannose--protein mannosyltransferase 1;
GN   Name=POMT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2),
RP   ALTERNATIVE SPLICING, AND VARIANT ARG-251.
RC   TISSUE=Fetal brain;
RX   PubMed=10366449; DOI=10.1006/geno.1999.5819;
RA   Perez Jurado L.A., Coloma A., Cruces J.;
RT   "Identification of a human homolog of the Drosophila rotated abdomen
RT   gene (POMT1) encoding a putative protein O-mannosyl-transferase, and
RT   assignment to human chromosome 9q34.1.";
RL   Genomics 58:171-180(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 53-747 (ISOFORM 1), AND VARIANT
RP   ARG-251.
RC   TISSUE=Hippocampus, Ileal mucosa, Signet-ring cell carcinoma, and
RC   Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, AND VARIANTS MDDGA1 ARG-76 AND ASP-428.
RX   PubMed=12369018; DOI=10.1086/342975;
RA   Beltran-Valero de Bernabe D., Currier S., Steinbrecher A., Celli J.,
RA   van Beusekom E., van der Zwaag B., Kayserili H., Merlini L.,
RA   Chitayat D., Dobyns W.B., Cormand B., Lehesjoki A.-E., Cruces J.,
RA   Voit T., Walsh C.A., van Bokhoven H., Brunner H.G.;
RT   "Mutations in the O-mannosyltransferase gene POMT1 give rise to the
RT   severe neuronal migration disorder Walker-Warburg syndrome.";
RL   Am. J. Hum. Genet. 71:1033-1043(2002).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, ENZYME REGULATION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=14699049; DOI=10.1073/pnas.0307228101;
RA   Manya H., Chiba A., Yoshida A., Wang X., Chiba Y., Jigami Y.,
RA   Margolis R.U., Endo T.;
RT   "Demonstration of mammalian protein O-mannosyltransferase activity:
RT   coexpression of POMT1 and POMT2 required for enzymatic activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:500-505(2004).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-471.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [10]
RP   VARIANT MDDGA1 LEU-421 DEL.
RX   PubMed=15037715; DOI=10.1212/01.WNL.0000115386.28769.65;
RA   Kim D.-S., Hayashi Y.K., Matsumoto H., Ogawa M., Noguchi S.,
RA   Murakami N., Sakuta R., Mochizuki M., Michele D.E., Campbell K.P.,
RA   Nonaka I., Nishino I.;
RT   "POMT1 mutation results in defective glycosylation and loss of
RT   laminin-binding activity in alpha-DG.";
RL   Neurology 62:1009-1011(2004).
RN   [11]
RP   VARIANT MDDGA1 ARG-537.
RX   PubMed=15637732; DOI=10.1002/ajmg.a.30487;
RA   Currier S.C., Lee C.K., Chang B.S., Bodell A.L., Pai G.S., Job L.,
RA   Lagae L.G., Al-Gazali L.I., Eyaid W.M., Enns G., Dobyns W.B.,
RA   Walsh C.A.;
RT   "Mutations in POMT1 are found in a minority of patients with Walker-
RT   Warburg syndrome.";
RL   Am. J. Med. Genet. A 133:53-57(2005).
RN   [12]
RP   VARIANT MDDGC1 PRO-200.
RX   PubMed=15792865; DOI=10.1016/j.nmd.2005.01.013;
RA   Balci B., Uyanik G., Dincer P., Gross C., Willer T., Talim B.,
RA   Haliloglu G., Kale G., Hehr U., Winkler J., Topaloglu H.;
RT   "An autosomal recessive limb girdle muscular dystrophy (LGMD2) with
RT   mild mental retardation is allelic to Walker-Warburg syndrome (WWS)
RT   caused by a mutation in the POMT1 gene.";
RL   Neuromuscul. Disord. 15:271-275(2005).
RN   [13]
RP   VARIANTS MDDGB1 ARG-65; MET-140 DEL; CYS-582 AND HIS-590, VARIANTS
RP   MDDGA1 CYS-105; HIS-105 AND VAL-207, AND VARIANTS PHE-285 AND LYS-522.
RX   PubMed=16575835; DOI=10.1002/humu.20313;
RA   van Reeuwijk J., Maugenre S., van den Elzen C., Verrips A.,
RA   Bertini E., Muntoni F., Merlini L., Scheffer H., Brunner H.G.,
RA   Guicheney P., van Bokhoven H.;
RT   "The expanding phenotype of POMT1 mutations: from Walker-Warburg
RT   syndrome to congenital muscular dystrophy, microcephaly, and mental
RT   retardation.";
RL   Hum. Mutat. 27:453-459(2006).
RN   [14]
RP   VARIANTS MDDGB1 ARG-65; HIS-590 AND THR-669.
RX   PubMed=16717220; DOI=10.1212/01.wnl.0000216145.66476.36;
RA   D'Amico A., Tessa A., Bruno C., Petrini S., Biancheri R., Pane M.,
RA   Pedemonte M., Ricci E., Falace A., Rossi A., Mercuri E.,
RA   Santorelli F.M., Bertini E.;
RT   "Expanding the clinical spectrum of POMT1 phenotype.";
RL   Neurology 66:1564-1567(2006).
RN   [15]
RP   VARIANTS MDDGB1 ARG-65 AND ARG-537.
RX   PubMed=19299310; DOI=10.1212/01.wnl.0000346518.68110.60;
RA   Mercuri E., Messina S., Bruno C., Mora M., Pegoraro E., Comi G.P.,
RA   D'Amico A., Aiello C., Biancheri R., Berardinelli A., Boffi P.,
RA   Cassandrini D., Laverda A., Moggio M., Morandi L., Moroni I., Pane M.,
RA   Pezzani R., Pichiecchio A., Pini A., Minetti C., Mongini T.,
RA   Mottarelli E., Ricci E., Ruggieri A., Saredi S., Scuderi C., Tessa A.,
RA   Toscano A., Tortorella G., Trevisan C.P., Uggetti C., Vasco G.,
RA   Santorelli F.M., Bertini E.;
RT   "Congenital muscular dystrophies with defective glycosylation of
RT   dystroglycan: a population study.";
RL   Neurology 72:1802-1809(2009).
CC   -!- FUNCTION: Transfers mannosyl residues to the hydroxyl group of
CC       serine or threonine residues. Coexpression of both POMT1 and POMT2
CC       is necessary for enzyme activity, expression of either POMT1 or
CC       POMT2 alone is insufficient. {ECO:0000269|PubMed:12369018,
CC       ECO:0000269|PubMed:14699049}.
CC   -!- CATALYTIC ACTIVITY: Dolichyl D-mannosyl phosphate + protein =
CC       dolichyl phosphate + O-D-mannosylprotein.
CC       {ECO:0000269|PubMed:14699049}.
CC   -!- ENZYME REGULATION: Slightly activated by Mg(2+) and inhibited by
CC       both Ca(+) and Mn(2+). EDTA ha no effect on activity in vitro.
CC       {ECO:0000269|PubMed:14699049}.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Interacts with POMT2. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:14699049}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:14699049}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q9Y6A1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y6A1-2; Sequence=VSP_007591;
CC       Name=3;
CC         IsoId=Q9Y6A1-3; Sequence=VSP_007590, VSP_007591;
CC       Name=4;
CC         IsoId=Q9Y6A1-4; Sequence=VSP_041024, VSP_007591;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in testis,
CC       heart and pancreas. Detected at lower levels in kidney, skeletal
CC       muscle, brain, placenta, lung and liver.
CC   -!- DISEASE: Muscular dystrophy-dystroglycanopathy congenital with
CC       mental retardation B1 (MDDGB1) [MIM:613155]: An autosomal
CC       recessive disorder characterized by congenital muscular dystrophy
CC       associated with mental retardation and mild structural brain
CC       abnormalities. {ECO:0000269|PubMed:16575835,
CC       ECO:0000269|PubMed:16717220, ECO:0000269|PubMed:19299310}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Muscular dystrophy-dystroglycanopathy congenital with
CC       brain and eye anomalies A1 (MDDGA1) [MIM:236670]: An autosomal
CC       recessive disorder characterized by congenital muscular dystrophy
CC       associated with cobblestone lissencephaly and other brain
CC       anomalies, eye malformations, profound mental retardation, and
CC       death usually in the first years of life. Included diseases are
CC       the more severe Walker-Warburg syndrome and the slightly less
CC       severe muscle-eye-brain disease. {ECO:0000269|PubMed:12369018,
CC       ECO:0000269|PubMed:15037715, ECO:0000269|PubMed:15637732,
CC       ECO:0000269|PubMed:16575835}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Muscular dystrophy-dystroglycanopathy limb-girdle C1
CC       (MDDGC1) [MIM:609308]: An autosomal recessive degenerative
CC       myopathy associated with mild mental retardation without any
CC       obvious structural brain abnormality. An abnormal alpha-
CC       dystroglycan pattern in observed in the muscle.
CC       {ECO:0000269|PubMed:15792865}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 39 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91135.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA91190.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF095136; AAD41245.1; -; mRNA.
DR   EMBL; AF095150; AAD41246.1; -; Genomic_DNA.
DR   EMBL; AF095138; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095139; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095140; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095141; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095142; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095143; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095144; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095145; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095146; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095147; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095148; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AF095149; AAD41246.1; JOINED; Genomic_DNA.
DR   EMBL; AK000391; BAA91135.1; ALT_INIT; mRNA.
DR   EMBL; AK000475; BAA91190.1; ALT_INIT; mRNA.
DR   EMBL; AK295561; BAG58462.1; -; mRNA.
DR   EMBL; AK074874; BAG52022.1; -; mRNA.
DR   EMBL; AK074888; BAC11269.1; -; mRNA.
DR   EMBL; AL358781; CAI40220.1; -; Genomic_DNA.
DR   EMBL; AL358781; CAI40221.1; -; Genomic_DNA.
DR   EMBL; AL358781; CAI40223.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW87978.1; -; Genomic_DNA.
DR   EMBL; BC022877; AAH22877.3; -; mRNA.
DR   EMBL; BC065268; AAH65268.1; -; mRNA.
DR   CCDS; CCDS43894.1; -. [Q9Y6A1-2]
DR   CCDS; CCDS43895.1; -. [Q9Y6A1-3]
DR   CCDS; CCDS48045.1; -. [Q9Y6A1-4]
DR   CCDS; CCDS6943.1; -. [Q9Y6A1-1]
DR   RefSeq; NP_001070833.1; NM_001077365.1. [Q9Y6A1-2]
DR   RefSeq; NP_001070834.1; NM_001077366.1. [Q9Y6A1-3]
DR   RefSeq; NP_001129585.1; NM_001136113.1. [Q9Y6A1-2]
DR   RefSeq; NP_001129586.1; NM_001136114.1. [Q9Y6A1-4]
DR   RefSeq; NP_009102.3; NM_007171.3.
DR   RefSeq; XP_005272213.1; XM_005272156.1. [Q9Y6A1-1]
DR   UniGene; Hs.522449; -.
DR   ProteinModelPortal; Q9Y6A1; -.
DR   BioGrid; 115834; 32.
DR   IntAct; Q9Y6A1; 2.
DR   STRING; 9606.ENSP00000361302; -.
DR   CAZy; GT39; Glycosyltransferase Family 39.
DR   iPTMnet; Q9Y6A1; -.
DR   PhosphoSitePlus; Q9Y6A1; -.
DR   BioMuta; POMT1; -.
DR   DMDM; 332278226; -.
DR   PaxDb; Q9Y6A1; -.
DR   PeptideAtlas; Q9Y6A1; -.
DR   PRIDE; Q9Y6A1; -.
DR   Ensembl; ENST00000341012; ENSP00000343034; ENSG00000130714. [Q9Y6A1-3]
DR   Ensembl; ENST00000372228; ENSP00000361302; ENSG00000130714. [Q9Y6A1-1]
DR   Ensembl; ENST00000402686; ENSP00000385797; ENSG00000130714. [Q9Y6A1-2]
DR   Ensembl; ENST00000404875; ENSP00000384531; ENSG00000130714. [Q9Y6A1-4]
DR   Ensembl; ENST00000423007; ENSP00000404119; ENSG00000130714. [Q9Y6A1-2]
DR   GeneID; 10585; -.
DR   KEGG; hsa:10585; -.
DR   UCSC; uc004cau.4; human. [Q9Y6A1-1]
DR   CTD; 10585; -.
DR   DisGeNET; 10585; -.
DR   GeneCards; POMT1; -.
DR   GeneReviews; POMT1; -.
DR   HGNC; HGNC:9202; POMT1.
DR   HPA; HPA065252; -.
DR   MalaCards; POMT1; -.
DR   MIM; 236670; phenotype.
DR   MIM; 607423; gene.
DR   MIM; 609308; phenotype.
DR   MIM; 613155; phenotype.
DR   neXtProt; NX_Q9Y6A1; -.
DR   OpenTargets; ENSG00000130714; -.
DR   Orphanet; 86812; Autosomal recessive limb-girdle muscular dystrophy type 2K.
DR   Orphanet; 370959; Congenital muscular dystrophy with cerebellar involvement.
DR   Orphanet; 370968; Congenital muscular dystrophy with intellectual disability.
DR   Orphanet; 370980; Congenital muscular dystrophy without intellectual disability.
DR   Orphanet; 588; Muscle-eye-brain disease.
DR   Orphanet; 899; Walker-Warburg syndrome.
DR   PharmGKB; PA33527; -.
DR   eggNOG; KOG3359; Eukaryota.
DR   eggNOG; COG1928; LUCA.
DR   GeneTree; ENSGT00870000136482; -.
DR   HOVERGEN; HBG053637; -.
DR   InParanoid; Q9Y6A1; -.
DR   KO; K00728; -.
DR   OMA; FFYVHLI; -.
DR   OrthoDB; EOG091G02QX; -.
DR   PhylomeDB; Q9Y6A1; -.
DR   TreeFam; TF300552; -.
DR   BRENDA; 2.4.1.109; 2681.
DR   Reactome; R-HSA-5173105; O-linked glycosylation.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; POMT1; human.
DR   GeneWiki; POMT1; -.
DR   GenomeRNAi; 10585; -.
DR   PRO; PR:Q9Y6A1; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000130714; -.
DR   ExpressionAtlas; Q9Y6A1; baseline and differential.
DR   Genevisible; Q9Y6A1; HS.
DR   GO; GO:0001669; C:acrosomal vesicle; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; TAS:ProtInc.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0004169; F:dolichyl-phosphate-mannose-protein mannosyltransferase activity; IBA:GO_Central.
DR   GO; GO:0000030; F:mannosyltransferase activity; TAS:ProtInc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc.
DR   GO; GO:0071712; P:ER-associated misfolded protein catabolic process; IBA:GO_Central.
DR   GO; GO:0030198; P:extracellular matrix organization; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:1904100; P:positive regulation of protein O-linked glycosylation; IEA:Ensembl.
DR   GO; GO:0006493; P:protein O-linked glycosylation; TAS:Reactome.
DR   InterPro; IPR027005; GlyclTrfase_39-like.
DR   InterPro; IPR003342; Glyco_trans_39/83.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR032421; PMT_4TMC.
DR   PANTHER; PTHR10050; PTHR10050; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF02366; PMT; 1.
DR   Pfam; PF16192; PMT_4TMC; 1.
DR   SMART; SM00472; MIR; 3.
DR   SUPFAM; SSF82109; SSF82109; 1.
DR   PROSITE; PS50919; MIR; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome;
KW   Congenital muscular dystrophy; Disease mutation; Dystroglycanopathy;
KW   Endoplasmic reticulum; Glycoprotein; Glycosyltransferase;
KW   Limb-girdle muscular dystrophy; Lissencephaly; Membrane;
KW   Metal-binding; Polymorphism; Reference proteome; Repeat; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    747       Protein O-mannosyl-transferase 1.
FT                                /FTId=PRO_0000121484.
FT   TRANSMEM      8     28       Helical. {ECO:0000255}.
FT   TRANSMEM     40     60       Helical. {ECO:0000255}.
FT   TRANSMEM     68     88       Helical. {ECO:0000255}.
FT   TRANSMEM     99    119       Helical. {ECO:0000255}.
FT   TRANSMEM    122    142       Helical. {ECO:0000255}.
FT   TRANSMEM    154    174       Helical. {ECO:0000255}.
FT   TRANSMEM    183    203       Helical. {ECO:0000255}.
FT   TRANSMEM    206    226       Helical. {ECO:0000255}.
FT   TRANSMEM    269    289       Helical. {ECO:0000255}.
FT   TRANSMEM    597    617       Helical. {ECO:0000255}.
FT   TRANSMEM    636    656       Helical. {ECO:0000255}.
FT   TRANSMEM    661    681       Helical. {ECO:0000255}.
FT   DOMAIN      318    381       MIR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      392    449       MIR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   DOMAIN      453    513       MIR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00131}.
FT   CARBOHYD    435    435       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    471    471       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    539    539       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    117       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041024.
FT   VAR_SEQ       1     54       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:16303743}.
FT                                /FTId=VSP_007590.
FT   VAR_SEQ     234    255       Missing (in isoform 2, isoform 3 and
FT                                isoform 4). {ECO:0000303|PubMed:10366449,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:16303743}.
FT                                /FTId=VSP_007591.
FT   VARIANT      65     65       G -> R (in MDDGB1; dbSNP:rs119462983).
FT                                {ECO:0000269|PubMed:16575835,
FT                                ECO:0000269|PubMed:16717220,
FT                                ECO:0000269|PubMed:19299310}.
FT                                /FTId=VAR_065027.
FT   VARIANT      76     76       G -> R (in MDDGA1; dbSNP:rs28941782).
FT                                {ECO:0000269|PubMed:12369018}.
FT                                /FTId=VAR_015734.
FT   VARIANT     105    105       R -> C (in MDDGA1; severe Walker-Warburg
FT                                syndrome). {ECO:0000269|PubMed:16575835}.
FT                                /FTId=VAR_065028.
FT   VARIANT     105    105       R -> H (in MDDGA1; severe Walker-Warburg
FT                                syndrome). {ECO:0000269|PubMed:16575835}.
FT                                /FTId=VAR_065029.
FT   VARIANT     140    140       Missing (in MDDGB1).
FT                                {ECO:0000269|PubMed:16575835}.
FT                                /FTId=VAR_065030.
FT   VARIANT     200    200       A -> P (in MDDGC1; a common founder
FT                                mutation; dbSNP:rs119462982).
FT                                {ECO:0000269|PubMed:15792865}.
FT                                /FTId=VAR_022661.
FT   VARIANT     207    207       G -> V (in MDDGA1; severe Walker-Warburg
FT                                syndrome). {ECO:0000269|PubMed:16575835}.
FT                                /FTId=VAR_065031.
FT   VARIANT     251    251       Q -> R (in dbSNP:rs2296949).
FT                                {ECO:0000269|PubMed:10366449,
FT                                ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_034390.
FT   VARIANT     251    251       Q -> W (requires 2 nucleotide
FT                                substitutions; dbSNP:rs3887873).
FT                                /FTId=VAR_034389.
FT   VARIANT     285    285       L -> F (in dbSNP:rs201073763).
FT                                {ECO:0000269|PubMed:16575835}.
FT                                /FTId=VAR_065032.
FT   VARIANT     327    327       V -> I (in dbSNP:rs4740164).
FT                                /FTId=VAR_034391.
FT   VARIANT     421    421       Missing (in MDDGA1; associated with the
FT                                loss of function of alpha dystroglycan as
FT                                a matrix receptor).
FT                                {ECO:0000269|PubMed:15037715}.
FT                                /FTId=VAR_022662.
FT   VARIANT     428    428       V -> D (in MDDGA1).
FT                                {ECO:0000269|PubMed:12369018}.
FT                                /FTId=VAR_015735.
FT   VARIANT     433    433       D -> E (in dbSNP:rs11243406).
FT                                /FTId=VAR_034392.
FT   VARIANT     522    522       R -> K (in dbSNP:rs117985576).
FT                                {ECO:0000269|PubMed:16575835}.
FT                                /FTId=VAR_065033.
FT   VARIANT     537    537       S -> R (in MDDGA1 and MDDGB1;
FT                                dbSNP:rs150367385).
FT                                {ECO:0000269|PubMed:15637732,
FT                                ECO:0000269|PubMed:19299310}.
FT                                /FTId=VAR_026697.
FT   VARIANT     582    582       W -> C (in MDDGB1; dbSNP:rs119462984).
FT                                {ECO:0000269|PubMed:16575835}.
FT                                /FTId=VAR_065034.
FT   VARIANT     590    590       Q -> H (in MDDGB1; dbSNP:rs119462986).
FT                                {ECO:0000269|PubMed:16575835,
FT                                ECO:0000269|PubMed:16717220}.
FT                                /FTId=VAR_065035.
FT   VARIANT     669    669       A -> T (in MDDGB1; dbSNP:rs119462987).
FT                                {ECO:0000269|PubMed:16717220}.
FT                                /FTId=VAR_065036.
FT   CONFLICT     37     37       P -> Q (in Ref. 6; AAH22877).
FT                                {ECO:0000305}.
FT   CONFLICT    143    143       E -> K (in Ref. 1; AAD41245).
FT                                {ECO:0000305}.
FT   CONFLICT    147    147       I -> V (in Ref. 2; BAG58462).
FT                                {ECO:0000305}.
FT   CONFLICT    178    178       K -> E (in Ref. 6; AAH22877).
FT                                {ECO:0000305}.
FT   CONFLICT    377    377       I -> V (in Ref. 6; AAH22877).
FT                                {ECO:0000305}.
FT   CONFLICT    665    665       H -> L (in Ref. 3; BAC11269).
FT                                {ECO:0000305}.
FT   CONFLICT    696    697       SI -> NS (in Ref. 1; AAD41245).
FT                                {ECO:0000305}.
FT   CONFLICT    739    739       S -> G (in Ref. 2; BAA91135).
FT                                {ECO:0000305}.
SQ   SEQUENCE   747 AA;  84881 MW;  6E1D26C87FF5D9C5 CRC64;
     MWGFLKRPVV VTADINLSLV ALTGMGLLSR LWRLTYPRAV VFDEVYYGQY ISFYMKQIFF
     LDDSGPPFGH MVLALGGYLG GFDGNFLWNR IGAEYSSNVP VWSLRLLPAL AGALSVPMAY
     QIVLELHFSH CAAMGAALLM LIENALITQS RLMLLESVLI FFNLLAVLSY LKFFNCQKHS
     PFSLSWWFWL TLTGVACSCA VGIKYMGVFT YVLVLGVAAV HAWHLLGDQT LSNVGADVQC
     CMRPACMGQM QMSQGVCVFC HLLARAVALL VIPVVLYLLF FYVHLILVFR SGPHDQIMSS
     AFQASLEGGL ARITQGQPLE VAFGSQVTLR NVFGKPVPCW LHSHQDTYPM IYENGRGSSH
     QQQVTCYPFK DVNNWWIVKD PRRHQLVVSS PPRPVRHGDM VQLVHGMTTR SLNTHDVAAP
     LSPHSQEVSC YIDYNISMPA QNLWRLEIVN RGSDTDVWKT ILSEVRFVHV NTSAVLKLSG
     AHLPDWGYRQ LEIVGEKLSR GYHGSTVWNV EEHRYGASQE QRERERELHS PAQVDVSRNL
     SFMARFSELQ WRMLALRSDD SEHKYSSSPL EWVTLDTNIA YWLHPRTSAQ IHLLGNIVIW
     VSGSLALAIY ALLSLWYLLR RRRNVHDLPQ DAWLRWVLAG ALCAGGWAVN YLPFFLMEKT
     LFLYHYLPAL TFQILLLPVV LQHISDHLCR SQLQRSIFSA LVVAWYSSAC HVSNTLRPLT
     YGDKSLSPHE LKALRWKDSW DILIRKH
//
